Insider Transactions in Q1 2025 at Seres Therapeutics, Inc. (MCRB)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Matthew R. Henn |
SELL
Open market or private sale
|
Direct |
3,953
-4.47%
|
$0
$0.81 P/Share
|
|
Feb 18
2025
|
Teresa L. Young |
SELL
Open market or private sale
|
Direct |
3,338
-3.31%
|
$0
$0.81 P/Share
|
|
Feb 18
2025
|
Lisa Von Moltke |
SELL
Open market or private sale
|
Direct |
4,416
-9.97%
|
$0
$0.81 P/Share
|
|
Feb 18
2025
|
Thomas Des Rosier Chief Legal Officer and EVP |
SELL
Open market or private sale
|
Direct |
4,300
-2.93%
|
$0
$0.81 P/Share
|
|
Feb 18
2025
|
Eric D. Shaff CEO and President |
SELL
Open market or private sale
|
Direct |
12,726
-6.21%
|
$0
$0.81 P/Share
|
|
Feb 15
2025
|
Matthew R. Henn |
BUY
Exercise of conversion of derivative security
|
Direct |
10,626
+5.75%
|
-
|
|
Feb 15
2025
|
Teresa L. Young |
BUY
Exercise of conversion of derivative security
|
Direct |
10,470
+4.98%
|
-
|
|
Feb 15
2025
|
Lisa Von Moltke |
BUY
Exercise of conversion of derivative security
|
Direct |
11,876
+12.24%
|
-
|
|
Feb 15
2025
|
Thomas Des Rosier Chief Legal Officer and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
11,564
+3.81%
|
-
|
|
Feb 15
2025
|
Eric D. Shaff CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
34,376
+7.84%
|
-
|